Atherosclerosis lesion is accelerated by persistent systemic inflammation but attenuated by saponins from Panax Notoginseng in rabbits

Journal of Medical Colleges of PLA

Volumn 23, Issue 1, 2008, Pages 38-44

  Yi, Jia ^a   Xiaohui, Li ^a   Ya, Liu ^a   Haigang, Zhang ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Atherosclerosis; Inflammation; Lipoprotein lipase; Saponins of panax notoginseng

Indexed keywords

ACETYLSALICYLIC ACID; CHOLESTEROL; LIPOPROTEIN LIPASE; PANAX NOTOGINSENG EXTRACT; SAPONIN DERIVATIVE; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; ZYMOSAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; LIPID DIET; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RABBIT; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 77950230562     PISSN: 10001948     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1000-1948(08)60007-6     Document Type: Article

References (22)

1. Paganini-Hill A, Lozano E, Fischberg G, et al. Infection and risk of ischemic stroke: differences among stroke subtypes. Stroke 2003, 34(2):452-457.
2. Elkind MS Inflammation, atherosclerosis, and stroke. Neurologist 2006, 12(3):140-148.
3. Sbarsi I, Falcone C, Boiocchi C, et al. Inflammation and atherosclerosis: the role of TNF and TNF receptors polymorphisms in coronary artery disease. Int J Immunopathol Pharmacol 2007, 20(1):145-154.
4. Schillinger M, Exner M, Mlekusch W, et al. Inflammation and carotid artery-risk for atherosclerosis study. Circulation 2005, 111(17):2203-2209.
5. van Oostrom AJ, van Wijk J, Cabezas MC Lipaemia, inflammation and atherosclerosis: novel opportunities in the understanding and treatment of atherosclerosis. Drugs 2004, 64(Suppl 2):19-41.
6. Paoletti R, Bolego C, Poli A, et al. Metabolic syndrome, inflammation and atherosclerosis. Vasc Health Risk Manag 2006, 2(2):145-152.
7. WANG Jing, HU Jinzhong Inhibitory effect of Panax notoginseng on the VSMC proliferation induced by hyperlipidemia serum. Zhongguo Zhong Yao Za Zhi 2006, 31(7):588-590. (In Chinese).
8. Cicero AF, Vitale G, Savino G, et al. Panax notoginseng effects on fibrinogen and lipid plasma level in rats fed on a high-fat diet. Phytother Res 2003, 17(2):174-178.
9. Chen SW, Li XH, Ye KH, et al. Total saponins of Panax notoginseng protected rabbit iliac artery against balloon endothelial denudation injury. Acta Pharmacol Sin 2004, 25(9):1151-1156.
10. Li SH, Chu Y Anti-infalmmatory effects of total saponins of Panax notoginseng. Acta Pharmacol Sin 1999, 20(6):551-554.
11. Stoll G, Bendszus M Inflammation and atherosclerosis: novel insights into plaque formation and destabilization. Stroke 2006, 37(7):1923-1932.
12. Jongstra Bilen J, Haidari M, Zhu SN, et al. Low-grade chronic inflammation in regions of the normal mouse arterial intima predisposed to atherosclerosis. J Exp Med 2006, 203(9):2073-2083.
13. Volman TJ, Hendriks T, Goris RJ Zymosan-induced generalized inflammation: experimental studies into mechanisms leading to multiple organ dysfunction syndrome. Shock 2005, 23(4):291-297.
14. Homma Y Predictors of atherosclerosis. J Atheroscler Thromb 2004, 11(5):265-270.
15. Eckel RH Lipoprotein lipase, a multifunctional enzyme relevant to common metabolic diseases. N Engl J Med 1989, 320(16):1060-1068.
16. Jensen DR, Schlaepfer IR, Morin CL, et al. Prevention of diet-induced obesity in transgenic mice overexpressing skeletal muscle lipoprotein lipase. AmJ Physiol 1997, 273(2):683-689.
17. Koike T, Liang J, Wang X, et al. Overexpression of lipoprotein lipase in transgenic watanabe heritable hyperlipidemic rabbits improves hyperlipidemia and obesity. J Biol Chem 2004, 279(9):7521-7529.
18. Yin WD, Liao DF, Kusunok M NO-1886 decreases ectopic lipid deposition and protects pancreatic cells in diet-induced diabetic swine. J Endocrinol 2004, 180(3):399-408.
19. Kusunoki M, Hara T, Tsutsumi K, et al. The lipoprotein lipase activator, NO-1886, suppresses fat accumulation and insulin resistance in high-fat fed rats. Diabetologia 2000, 43(7):875-880.
20. Henderson HE, Kastelein JJ, Zwinderman AH, et al. Lipoprotein lipase activity is decreased in a large cohort of patients with coronary artery disease and is associated with changes in lipids and lipoproteins. J Lipid Res 1999, 40(4):735-743.
21. von Eynatten M, Schneider JG, Humpert PM Decreased plasma lipoprotein lipase in hypoadiponectinemia: an association independent of systemic inflammation and insulin resistance. Diabetes Care 2004, 27(12):2925-2929.
22. Wang Y, Peng D, Huang W, et al. Mechanism of altered TNF-alpha expression by macrophage and the modulatory effect of Panax notoginseng saponins in scald mice. Burns 2006, 32(7):846-852.